Evaluation of Clinical and Laboratory Features of Rhinovirus Infections in Children

Abstract

Objective Our aim in this study was to evaluate the clinical characteristics of patients afflicted with rhinovirus (RV) infections, compare their laboratory findings with a healthy population, determine the features of the clinical course of the illness in individuals with a chronic disease, and set out the risk factors involved in the need for mechanical ventilation (MV).

Methods The study was conducted on 318 pediatric patients aged 0 to 18 years diagnosed with RV infection. Patients were divided into two main groups, those with and without a chronic disease. The group with chronic disease was divided into four subgroups. Children with RV were compared with a control group of 231 healthy children.

Results The most common symptoms and signs were wheeze (65.4%), cough (65.1%), and tachypnea (50.3%). Compared with the healthy population, RV-positive patients showed significant increases in their white blood cell (WBC), neutrophil, and platelet counts, and in their delta neutrophil index and C-reactive protein values (all p < 0.001). The most important risk factors in terms of the need for MV were elevated WBC (odds ratio [OR] = 1.404, 95% confidence interval [CI]: 1.059–1.862), chronic lung disease (CLD) (OR = 5.196, 95% CI: 2.296–11.762), reticular involvement (OR = 3.132, 95% CI: 1.259–7.793), and lobar involvement (OR = 10.575, 95% CI: 13.434–32.564).

Conclusion It is of vital importance that individuals with asthma and CLD are closely monitored and protected during RV seasonal periods as they are most at risk of severe infection, which can require high-flow nasal cannula and MV.

Keywords

rhinovirus - mechanical ventilation - asthma - chronic lung disease - immunodeficiency - neurometabolic disease

Publication History

Received: 01 October 2023

Accepted: 25 March 2024

Article published online:
03 May 2024

• References

• 1 Peltola V, Waris M, Österback R, Susi P, Ruuskanen O, Hyypiä T. Rhinovirus transmission within families with children: incidence of symptomatic and asymptomatic infections. J Infect Dis 2008; 197 (03) 382-389
• 2 Do DH, Laus S, Leber A. et al. A one-step, real-time PCR assay for rapid detection of rhinovirus. J Mol Diagn 2010; 12 (01) 102-108
• 3 Howard LM, Johnson M, Gil AI. et al. Molecular epidemiology of rhinovirus detections in young children. Open Forum Infect Dis 2016; 3 (01) ofw001
• 4 Stobart CC, Nosek JM, Moore ML. Rhinovirus biology, antigenic diversity, and advancements in the design of a human rhinovirus vaccine. Front Microbiol 2017; 8 (DEC): 2412
• 5 Simasek M, Blandino DA. Treatment of the common cold. Am Fam Physician 2007; 75 (04) 515-520
• 6 Sherman AC, Babiker A, Sieben AJ. et al. The effect of SARS-CoV-2 mitigation strategies on seasonal respiratory viruses: a tale of two large metropolitan centers in the United States. Clin Infect Dis An Off Publ Infect Dis Soc Am 2021; 72 (05) 154-157
• 7 Calvo C, García-García ML, Blanco C, Pozo F, Flecha IC, Pérez-Breña P. Role of rhinovirus in hospitalized infants with respiratory tract infections in Spain. Pediatr Infect Dis J 2007; 26 (10) 904-908
• 8 Poole S, Brendish NJ, Tanner AR, Clark TW. Physical distancing in schools for SARS-CoV-2 and the resurgence of rhinovirus. Lancet Respir Med 2020; 8 (12) e92-e93
• 9 Wu A, Mihaylova VT, Landry ML, Foxman EF. Interference between rhinovirus and influenza A virus: a clinical data analysis and experimental infection study. Lancet Microbe 2020; 1 (06) e254-e262
• 10 Iwane MK, Prill MM, Lu X. et al. Human rhinovirus species associated with hospitalizations for acute respiratory illness in young US children. J Infect Dis 2011; 204 (11) 1702-1710
• 11 Takashita E, Kawakami C, Momoki T. et al. Increased risk of rhinovirus infection in children during the coronavirus disease-19 pandemic. Influenza Other Respir Viruses 2021; 15 (04) 488-494
• 12 Miller EK, Lu X, Erdman DD. et al; New Vaccine Surveillance Network. Rhinovirus-associated hospitalizations in young children. J Infect Dis 2007; 195 (06) 773-781
• 13 El-Sahly HM, Atmar RL, Glezen WP, Greenberg SB. Spectrum of clinical illness in hospitalized patients with “common cold” virus infections. Clin Infect Dis 2000; 31 (01) 96-100
• 14 Costa LF, Queiróz DA, Lopes da Silveira H. et al. Human rhinovirus and disease severity in children. Pediatrics 2014; 133 (02) e312-e321
• 15 To KKW, Yip CCY, Yuen KY. Rhinovirus - from bench to bedside. J Formos Med Assoc 2017; 116 (07) 496-504
• 16 Pöyry H, Raappana A, Kiviniemi M. et al. Etiology of infectious diseases in acutely ill children at a pediatric hospital in Finland. Pediatr Infect Dis J 2021; 40 (06) e245-e247
• 17 Johnston SL. The role of viral and atypical bacterial pathogens in asthma pathogenesis. Pediatr Pulmonol Suppl 1999; 18: 141-143
• 18 Rubner FJ, Jackson DJ, Evans MD. et al. Early life rhinovirus wheezing, allergic sensitization, and asthma risk at adolescence. J Allergy Clin Immunol 2017; 139 (02) 501-507
• 19 Hough KP, Curtiss ML, Blain TJ. et al. Airway remodeling in asthma. Front Med (Lausanne) 2020; 7: 191
• 20 Sanchez-Codez MI, Moyer K, Benavente-Fernández I, Leber AL, Ramilo O, Mejias A. Viral loads and disease severity in children with rhinovirus-associated illnesses. Viruses 2021; 13 (02) 295
• 21 Chu HY, Englund JA, Strelitz B. et al. Rhinovirus disease in children seeking care in a tertiary pediatric emergency department. J Pediatric Infect Dis Soc 2016; 5 (01) 29-38